IP Library Granted Patent US 8,440,458
Granted Patent B2
US 8,440,458 · App. 13/397,323 · Granted May 14, 2013

Process for the culturing of cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,458
App. No.
13/397,323
Granted
May 14, 2013
Kind
B2
Abstract

The invention relates to a process for the culturing of cells, preferably E1-immortalized HER cells, more preferably PER.C6 cells in a reactor in suspension in a cell culture medium, wherein the cells produce a biological substance, preferably an antibody, wherein at least one cell culture medium component is fed to the cell culture and wherein the cell culture comprising the cells, the biological substance and cell culture medium is circulated over a separation system and wherein the separation system separates the biological substance from substances having a lower molecular weight than the biological substance and wherein the biological substance is retained in or fed back into the reactor. Preferably part of the substances of lower molecular weight is continuously removed from the cell culture.

Claims (39)

1. A cell culture comprising

(a) cell culture medium;

(b) animal cells having a viable cell density of at least 50×10 6 suspended cells/mL of cell culture medium; and

(c) a biological substance having a concentration of at least 5 g/L of cell culture medium;

wherein the cell culture is directly obtained from a reactor.

2. The cell culture of claim 1 , wherein the cell culture is a cell culture removal stream from the reactor.

3. The cell culture of claim 1 , wherein the animal cells have a viable cell density of at least 80×10 6 suspended cells/mL of cell culture medium.

4. The cell culture of claim 1 , wherein the animal cells have a viable cell density of at least 150×10 6 suspended cells/mL of cell culture medium.

5. The cell culture of claim 1 , wherein the concentration of biological substance is at least 10 g/L.

6. The cell culture of claim 1 , wherein the animal cells are selected from the group consisting of Chinese hamster ovary (CHO) cells, Baby hamster kidney (BHK) cells, myeloma cells, HER cells, mouse cells, and PER.C6 cells.

7. The cell culture of claim 1 , wherein the biological substance is a protein.

8. The cell culture of claim 7 , wherein the protein is a recombinant protein.

9. The cell culture of claim 1 , wherein the cell culture comprises at least two liters of cell culture media.

10. The cell culture of claim 9 , wherein the animal cells have a viable cell density of at least 80×10 6 suspended cells/mL of cell culture medium.

11. The cell culture of claim 9 , wherein the animal cells have a viable cell density of at least 150×10 6 suspended cells/mL of cell culture medium.

12. The cell culture of claim 9 , wherein the concentration of biological substance is at least 10 g/L.

13. The cell culture of claim 9 , wherein the animal cells are selected from the group consisting of Chinese hamster ovary (CHO) cells, Baby hamster kidney (BHK) cells, myeloma cells, HER cells, mouse cells, and PER.C6 cells.

14. The cell culture of claim 9 , wherein the biological substance is a protein.

15. The cell culture of claim 14 , wherein the protein is a recombinant protein.

16. A combination, comprising

(a) cell culture, comprising

(i) cell culture medium;

(ii) animal cells having a viable cell density of at least 50×10 6 suspended cells/mL of cell culture medium; and

(ii) a biological substance having a concentration of at least 5 g/L of cell culture medium; and

(b) a reactor;

wherein the cell culture is within the reactor.

17. The combination of claim 16 , wherein the animal cells have a viable cell density of at least 80×10 6 suspended cells/mL of cell culture medium.

18. The combination of claim 16 , wherein the animal cells have a viable cell density of at least 150×10 6 suspended cells/mL of cell culture medium.

19. The combination of claim 16 , wherein the concentration of biological substance is at least 10 g/L.

20. The combination of claim 16 , wherein the animal cells are selected from the group consisting of Chinese hamster ovary (CHO) cells, Baby hamster kidney (BHK) cells, myeloma cells, HER cells, mouse cells, and PER.C6 cells.

21. The combination of claim 16 , wherein the biological substance is a protein.

22. The combination of claim 21 , wherein the protein is a recombinant protein.

23. The combination of claim 16 , wherein the cell culture comprises at least two liters of cell culture medium.

24. The combination of claim 23 , wherein the animal cells have a viable cell density of at least 80×10 6 suspended cells/mL of cell culture medium.

25. The combination of claim 23 , wherein the animal cells have a viable cell density of at least 150×10 6 suspended cells/mL of cell culture medium.

26. The combination of claim 23 , wherein the concentration of biological substance is at least 10 g/L.

27. The combination of claim 23 , wherein the animal cells are selected from the group consisting of Chinese hamster ovary (CHO) cells, Baby hamster kidney (BHK) cells, myeloma cells, HER cells, mouse cells, and PER.C6 cells.

28. The combination of claim 23 , wherein the biological substance is a protein.

29. The combination of claim 28 , wherein the protein is a recombinant protein.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2014
From: DSM IP ASSETS B.V.
To: JLL/DELTA DUTCH NEWCO B.V.
Reel/Frame 034282/0574 →
CHANGE OF NAME Recorded Dec 1, 2014
From: JLL/DELTA DUTCH NEWCO B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 034500/0795 →
CHANGE OF ADDRESS Recorded Dec 1, 2014
From: DPX HOLDINGS B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 034500/0851 →